Amalgamated Bank Oric Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

$13.6 Billion
Q3 2025

A detailed history of Amalgamated Bank transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 2,130 shares of ORIC stock, worth $27,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,130

Previous 2,130 -0.0%

Holding current value

$27,881

Previous $21,000 19.05%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$6.63 - $12.93 $5,396 - $10,525	814 Added 61.85%	2,130 $15,000
Q1 2024 Apr 23, 2024	SELL	$8.04 - $16.03 $16,795 - $33,486	-2,089 Reduced 61.35%	1,316 $18,000
Q4 2023 Feb 06, 2024	SELL	$5.41 - $9.43 $2,120 - $3,696	-392 Reduced 10.32%	3,405 $31,000
Q2 2023 Aug 11, 2023	BUY	$4.95 - $8.4 $18,795 - $31,894	3,797 New	3,797 $29,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.07 $10,875 - $28,477	-4,028 Closed	0 $0

Q1 2022 Jun 30, 2022	BUY	$4.54 - $16.1 $18,287 - $64,850	4,028 New	4,028 $22,000

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $518M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Oric Pharmaceuticals, Inc. Transaction History